These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 10606252

  • 1. Where do we stand with 5-fluorouracil?
    Schmoll HJ, Büchele T, Grothey A, Dempke W.
    Semin Oncol; 1999 Dec; 26(6):589-605. PubMed ID: 10606252
    [Abstract] [Full Text] [Related]

  • 2. Biomodulation of Fluorouracil in colorectal cancer.
    Ardalan B, Luis R, Jaime M, Franceschi D.
    Cancer Invest; 1998 Dec; 16(4):237-51. PubMed ID: 9589033
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacetyl-L-aspartic acid, and interferon alfa-2a in advanced colorectal cancer.
    Royce ME, McGarry W, Bready B, Dakhil SR, Belt RJ, Goodwin JW, Gray R, Hoff PM, Winn R, Pazdur R.
    J Clin Oncol; 1999 Oct; 17(10):3276-82. PubMed ID: 10506630
    [Abstract] [Full Text] [Related]

  • 6. Biomodulation of 5-fluorouracil with antifolates.
    Bertino JR.
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-52-S18-56. PubMed ID: 9420021
    [Abstract] [Full Text] [Related]

  • 7. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.
    Ragnhammar P, Blomgren H.
    Med Oncol; 1995 Sep; 12(3):187-201. PubMed ID: 8852401
    [No Abstract] [Full Text] [Related]

  • 8. The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
    Köhne CH, Wilke H, Schöffski P, Schmoll HJ.
    J Infus Chemother; 1996 Sep; 6(4):206-10. PubMed ID: 9229317
    [No Abstract] [Full Text] [Related]

  • 9. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
    Johnston PG, Benson AB, Catalano P, Rao MS, O'Dwyer PJ, Allegra CJ.
    J Clin Oncol; 2003 Mar 01; 21(5):815-9. PubMed ID: 12610179
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.
    J Infus Chemother; 1996 Mar 01; 6(3):149-51. PubMed ID: 9229328
    [Abstract] [Full Text] [Related]

  • 12. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
    Lokich JJ, Moore CL, Anderson NR.
    Cancer; 1996 Jul 15; 78(2):294-9. PubMed ID: 8674006
    [Abstract] [Full Text] [Related]

  • 13. [Infusiontherapy with 5-fluorouracil ("infusional" 5-FU) in solid tumors].
    Wilke H, Stahl M, Köster W, Vanhöfer U.
    Med Klin (Munich); 2000 Jun 15; 95 Suppl 1():3-8. PubMed ID: 10941246
    [Abstract] [Full Text] [Related]

  • 14. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 Jun 15; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 15. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.
    Benson AB.
    Oncology (Williston Park); 1998 Oct 15; 12(10 Suppl 7):28-34. PubMed ID: 9830622
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer.
    Grem JL.
    Oncology (Williston Park); 2001 Jan 15; 15(1 Suppl 2):13-9. PubMed ID: 11219972
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical modulation of 5-fluorouracil by PALA.
    O'Dwyer PJ.
    Cancer Invest; 1990 Jan 15; 8(2):261-2. PubMed ID: 2400945
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.